Clinical Chemistry

Brussels, Belgium

Clinical Chemistry

Brussels, Belgium
SEARCH FILTERS
Time filter
Source Type

— "China In-Vitro Diagnostics (IVD) Market, Forecast, Companies Analysis, Registration Rules" provides, wherever applicable and relevant, technical data of products, and sheds useful light on expected commercial production dates and current R&D status. This report will help the viewer in Better Decision Making. China In-vitro diagnostics market is expected to be triple its market size by the end of 2022 from its market size in 2016. China In-Vitro Diagnostics (IVD) Market sector is expected to grow with a double digit CAGR of 19.01% in future. With such a huge growth rate China is poised to become the world’s largest In–vitro Diagnostics (IVD) Market in the next few years for both domestic and foreign IVD products. The In–Vitro Diagnostics (IVD) Market in China has been growing rapidly over the past few years and is expected to grow steadily in the coming future, with major growth potential in segments such as contagious disease testing, chronic disease testing and diagnosis in early stages of disease. China In-Vitro Diagnostics (IVD) – Segment Analysis: Immunoassay has the highest market share in China IVD market, but after 2018 its market share will decline. China Microbiology Market has grown approximately 4 times in 2016 compared to its market value in 2007. China Molecular Testing Market is expected to grow almost five times in future from its present market. Contribution of Point of Care Testing (POCT) market is low compared to Hematology Market, Coagulation Market and Self Monitoring of Blood Glucose (SMBG) Market. Other segments such as Molecular testing, Clinical Chemistry and Microbiology are poised to be remarkable expansion in the near future. Roche is the leading company in the China IVD market. Factors Driving the Growth of In-Vitro Diagnostics (IVD) in China: Some of the key factors driving the growth of China IVD market are the rising incidences of chronic lifestyle diseases, public health awareness, growing aging population, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of hospitals and independent clinical laboratories. China In-Vitro Diagnostics (IVD) Market, Forecast, Companies Analysis, Registration Rules is the 5th edition report on In-Vitro Diagnostics by Renub Research. This presents a detailed account of In-Vitro Diagnostics Market, its 8 Segments Market, Companies In-Vitro Diagnostics Sales in China, Registration of In-Vitro Diagnostics in China. This 101 Page report with 36 Figures and 2 Tables studies the China IVD market from 6 view points: • Market and Forecast • Segment Wise Market & Forecast • Development Environment & Regulatory Status in China IVD market • Company Wise IVD Sales & Forecast • Growth Drivers for China In-Vitro Diagnostics • Challenges for China In-Vitro Diagnostics China IVD Market – Segment Analysis (2007 – 2022): 1. Clinical Chemistry Market & Forecast 2. Immunoassay Market & Forecast 3. Hematology Market & Forecast 4. Coagulation Market & Forecast 5. Microbiology Market & Forecast 6. Molecular Testing Market & Forecast 7. Self Monitoring of Blood Glucose (SMBG) Market & Forecast 8. Point of Care Testing (POCT) Market & Forecast Profiles of Private Clinical Labs and Diagnostic Services Companies in China • Zhejiang Di’an Diagnostics Technology Co., Ltd • ADICON Clinical Laboratories • Guangzhou Kingmed Diagnostics Center Co. Ltd. • Kindstar Global (Privately held) • BGI-Shenzhen (Privately held) • OriGene Technologies (Privately held) Major Points form TOC: 1. Executive Summary 2. China IVD Market & Market Share (2007 – 2022) 3. China IVD Companies Market Share (2011 – 2022) 4. China IVD Market by Segments (2007 – 2022) 5. Development Environment of Chinese IVD Industry 6. China: Health Insurance and Reimbursement Policies (New) 7. Registration of In Vitro Diagnostic Reagents in China 8. Medical Devices and Reagents Class Registration in China 9. China IVD Industry Drivers 10. China IVD Industry Challenges 11. China IVD Market – Company Sales Analysis (2011 – 2022) 12. Profiles of Select Private Clinical Labs and Diagnostic Services Companies About us: Orbis Research (our website: www.orbisresearch.com) is the most comprehensive database of market-related research. Serious researchers from across the globe seeking up-to-date information on the latest market trends with in-depth analyses turn to Orbis Research. Our massive database boasts authentic reports published by leading authors and publications. Orbis’ highly motivated and expert in-house team undertakes rigorous screening of the credentials of publishers and authors before accepting their submissions. Such vetting is imperative for internal quality control. For more information, please visit http://www.orbisresearch.com


DUBLIN, Apr. 25, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "Clinical Chemistry Analyzers Market Analysis By Product (Analyzers, Reagents), By Test (BMP, Electrolyte Panel, Liver Panel, Lipid Profile, Renal Profile, Thyroid Function Profile, Specialty...


DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Clinical Chemistry Analyzers Market 2017-2021" report to their offering. The global clinical chemistry analyzers market to grow at a CAGR of 2.24% during the period 2017-2021. The report, Global Clinical Chemistry Analyzers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The latest trend gaining momentum in the market is focus on fully automated clinical chemistry analyzers. In the last few years, clinical chemistry analyzers have been undergoing major changes in design and function. Typically, the POC monitoring of anticoagulation is done in outpatient anticoagulation clinics, cardiac surgery units, intensive care units (ICUs), and dialysis units with the help of different technologies. There are fully automated clinical chemistry analyzers available in the market that can perform functions such as recognition of sample and reagent bottles, tube sampling, cap piercing, automatic re-run, and dilution. According to the report, one of the major drivers for this market is rising demand for automation and integration of multiple processes. Clinical laboratories rely on progressing levels of automation to solve persistent challenges that include lack of skilled personnel, pressures to maintain cost while increasing productivity, and errors associated with manual processes. For more information about this report visit http://www.researchandmarkets.com/research/bhsz8m/global_clinical


News Article | April 17, 2017
Site: www.prweb.com

Visiun is pleased to announce the formation of a new Advisory Board, bringing together experts in the laboratory industry to provide input and perspective to the fast-changing environment of the hospital laboratory and Visiun’s leading laboratory analytics tool, Performance Insight™. The first member of the newly formed panel is Denise Uettwiller-Geiger, Ph.D., DLM(ASCP), award-winning Clinical Chemist, Director of Clinical Trials at John T Mather Hospital, and author of more than 80 clinical journal articles. Dr. Uettwiller-Geiger works in a laboratory that processes more than 2.4 million tests per year, assists with new technology and menu expansion, and serves as principal investigator for clinical trials in the areas of infectious disease, cardiac, point of care, and other new technologies. She also provides expert education, guidance and consultation to clinicians. As the first member of Visiun’s Advisory Board, Dr. Uettwiller-Geiger will use her expertise to provide strategic advice and recommendations to the expansion of Performance Insight and how it can best support laboratory management in improving operational performance most effectively. “Visiun is pleased to welcome Dr. Uettwiller-Geiger as the first member of our new Advisory Panel,” says Tom Joseph, Visiun President and CEO. “We look forward to working with Dr. Uettwiller-Geiger and receiving thoughtful guidance and recommendations from an industry leader like herself so we can best serve the laboratory community.” Dr. Uettwiller-Geiger received her Master of Health Sciences and an Advanced Certificate in Health Care Management, from the W. Averall Harriman School for Policy and Management, from Stony Brook University, Stony Brook, New York, and a PhD in Biomedical Science from Pacific Western University, Brentwood, California. In 2010, she received the American Association of Clinical Chemistry (AACC) Management Sciences Abstract Award for Outstanding Project; the National Academy of Clinical Biochemistry (NACB) Distinguished Abstract Award; and the Brookhaven’s Women’s Recognition Award for Science. In 2011, she received the Best Lab Practice Award from American Society of Clinical Pathology (ASCP) and the Siemens 2011 Inspired Healthcare Outcomes Award for her work in reducing MRSA infection rates. In 2015, she received the ICE Award (Increasing Clinical Effectiveness) from the Clinical Laboratory Management Association for her work in reducing hospital acquired infections. Spencer, M., Uettwiller-Geiger, D., Sanguinet, J., Johnson, H. B., & Graham, D. (2016). Infection preventionists and laboratorians: Case studies on successful collaboration. American Journal of Infection Control, 44(9), 964-968. Christenson, R. H., Jacobs, E., Uettwiller-Geiger, D., Estey, M. P., Lewandrowski, K., Koshy, T., Kupfer, K., Li, Y., & Wesenber, J. (2017). Comparison of 13 Commercially Available Cardiac Troponin Assays in a Multicenter North American Study. The Journal of Applied Laboratory Medicine, 1(5), 544-561. Visiun, Inc. is the leading provider of performance analytics to the laboratory industry. Headquartered in Ann Arbor, Michigan, Visiun has been providing services to the laboratory industry for over six years, with hundreds of laboratories installed across the United States. Performance Insight™, Visiun's core product, provides laboratory managers with a comprehensive suite of analytics that deliver immediate improvements in performance, efficiency, and quality. For more information, please visit http://www.visiun.com.


The global clinical chemistry analyzers market is expected to reach USD 16.0 billion by 2025 The growing prevalence of chronic diseases is anticipated to be responsible for the high urgency to adopt clinical chemistry analyzers, which thereby widens the scope for growth during the forecast period. In addition, growing base of geriatric and bariatric population, which is highly susceptible to chronic diseases, is presumed to impel the demand further. Consequently, the resultant high sample volume requiring high capability analyzing devices is driving the market growth. Moreover, increasing awareness pertaining to benefits associated with these devices is also a high impact rendering driver for clinical chemistry analyzers market. Advent of advanced chemistry analyzers has resulted in improved point-of-care testing capabilities, and thus created high potential growth opportunities for the market. In addition, technological advancements in preanalytical, analytical, and post analytical stages due to analyzing devices & reagents improved their diagnostic capabilities and overall efficiency, which is predicted to propel the growth further. These advancements include advent of microchips, sensors, chemometrics, and robotics. Furthermore, consistent efforts by public as well private healthcare organizations to increase the reliability of data have rapidly engendered the integration of automated chemistry analyzers and immunoassay systems, thereby resulting in overall reduction of workload in laboratories, thus propelling the demand. Further Key Findings From the Study Suggest: 4 Clinical Chemistry Analyzers Market: Product Estimates & Trend Analysis 4.1 Clinical Chemistry Analyzers Market: Product Movement Analysis 4.2 Analyzers 4.2.2 Small analyzers 4.2.3 Medium analyzers 4.2.4 Large analyzers 4.2.5 Very large analyzers 4.3 Reagents 4.3.2 Calibrators 4.3.3 Controls 4.3.4 Standards 4.3.5 Others 4.4 Others For more information about this report visit http://www.researchandmarkets.com/research/kbqjgr/clinical Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-clinical-chemistry-analyzers-market-analysis-2014-2017--2025-key-players-are-mindray-medical-international-johnson--johnson-and-fhoffmann-la-roche-300444290.html


— Given report “Global IVD Industry Analysis” analyzes the development of this market, with focus on the North America, EMEA, Asia-Pacific and Latin America markets. The major trends, growth drivers as well as issues faced by the market are discussed in detail in this report. The four major players: Siemens AG., Inc., Roche Holdings AG., Abbott Laboratories and Danaher Corp. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global IVD market along with the study of the regional markets. Complete report on In-Vitro Diagnostics industry spread across 81 pages with providing 4 company Profiles, 3 tables and 48 charts is now available at http://www.marketreportsonline.com/547317.html. Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In-vitro diagnostics (IVDs) tests are defined as tests executed outside a patient’s body which put analytical instruments, devices, reagents, calibrators and systems to use for checking of health status or diagnosing diseases. In-vitro means ‘in the glass’, as traditionally these tests were directed in glass test tubes. On the other hand, in-vivo diagnostics tests like electroencephalography, electrocardiography and imaging are executed inside a patient’s body. The global IVD market is segmented on the basis of product, technology used and test location. On the basis of product, this market can be divided into three sub segments; Reagents, analytical instruments and accessory products. By technologies employed, it can be segmented into seven sub segments; immunochemistry, SMBG, POCT, molecular diagnostics, clinical chemistry, microbiology, hematology and others. Further, depending upon test location, the market can be divided into three sub segments; labs, POC and self-test. Company Coverage of In-Vitro Diagnostics Industry: Siemens AG., Inc., Roche Holdings AG., Abbott Laboratories and Danaher Corp. Growth of the global IVD market is driven by several factors including rising cases of infectious disease, increasing diabetic patient base, increasing number of patients suffering from chronic ailments such as cancer. Additionally, escalating global aged population, rising GDP per capita and increasing healthcare expenditure per capita will act as a catalyst for market growth. Owing to the suitable demographical changes and rising disposable income coupled with improving basic infrastructure, developing regions such as Asia-Pacific and Latin America are expected to experience robust growth. However, the market growth is hindered by lack of customer adoption, unclear regulation of new advancing technologies and lack of basic facilities and infrastructure. Purchase a copy of this “Global In-Vitro Diagnostics Industry (IVD)” research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=547317. Few Points from List of Tables & Charts: Growing Cases and Prevalence of STDs in the US (2008-2015) The US approval for Companion Diagnostic (CD) Reagents Clinical Chemistry Market Position by Players (2015) Types of Diagnostics Types of IVD Products Types of IVD Tests IVD Market by Technology IVD Value Chain Analysis Global IVD Market by Value (2011-2015) Global IVD Market Forecast by Value (2016-2020) Global IVD Market by Region (2015) Global IVD Market by Product Type (2015) Global IVD Reagents Market Forecast by Value (2015-2020) Global IVD Market by Test Location (2015) Global IVD Market by Technology (2015) Global SMBG Market Forecast by Value (2015-2020) Global Clinical Chemistry Market Forecast by Value (2015-2020) Global Immunochemistry Market Forecast by Value (2015-2020) Global Immunochemistry Market by Applications (2015) Global Molecular Diagnostics Market by Value (2015-2020) Explore More Latest Reports on Healthcare Market at http://www.marketreportsonline.com/cat/healthcare-market-research.html. About Us: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports. For more information, please visit http://www.marketreportsonline.com/contacts/purchase.php?name=547317


DUBLIN, May 10, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Clinical Chemistry Analyzers Market 2017-2021" report to their offering. The global clinical chemistry analyzers market to grow at a CAGR of 2.24% during the period 2017-2021....


News Article | May 9, 2017
Site: www.prnewswire.com

Browse 72 market data Tables and 59 Figures spread through 155 Pages and in-depth TOC on "Poultry Diagnostics Market" Early buyers will receive 10% customization on this report. The growth of the market during the forecast period is mainly driven by the increase in the avian diseases outbreak and zoonotic diseases, increasing adoption of vaccinations, diagnostic monitoring of birds for the presence of disease pathogens, and the rising consumer concerns regarding food safety. However, high cost of production, lack of animal healthcare awareness, and trade disputes such as import bans are expected to restrain the overall market growth, to a certain extent, during the forecast period. In this report, the Poultry Diagnostics Market is segmented on the basis of product, service, and region. On the basis of product, the market has been further segmented by test type and disease type. The test type segment accounted for the largest share of the market in 2016. It is also expected to grow at the highest CAGR during the forecast period. This can be attributed to the wide use of ELISA tests for preliminary screening of all avian diseases coupled with their high sensitivity, specificity, and cost-effective nature. These tests are the most preferred for fast and accurate results. The disease type is also expected to register the fastest growth in the Poultry Diagnostics Market during the forecast period. This is due to the recent surge in avian influenza outbreaks in countries like the U.S., Canada, and China. This has led to the adoption of various test kits to detect and combat its spread. By service, the market is segmented by bacteriology, virology, and parasitology. The bacteriology service segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the regular bacterial testing on poultry undertaken by regions like Europe and Asia-Pacific to detect and prevent the spread of zoonotic diseases like salmonellosis, pasteurellosis, and mycoplasmosis. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific region is expected to witness the highest growth during the forecast period. Growth in this region can be attributed to the large livestock population in this region, growing demand of poultry-derived food products, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China. Some of the prominent players in the Poultry Diagnostics Market are IDEXX Laboratories, Inc. (U.S.), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (U.S.), Zoetis, Inc. (U.S.), GD Animal Health (Netherlands), IDVet (France), AffiniTech, LTD. (U.S.), AgroBioTek Internacional (Honduras), BioNote, Inc. (South Korea), BioChek (Netherlands), Boehringer Ingelheim (Germany), MEGACOR Diagnostik GmbH (Germany), and BioinGentech Biotechnologies, Inc. (Chile). Veterinary Diagnostics Market by Product (Instruments, Consumables, Services) by Technology (Diagnostic Imaging, Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics) by Animal (Dogs, Cats, Horses, Cattle, Pigs, Poultry) - Global forecast to 2021. MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


News Article | May 9, 2017
Site: www.prnewswire.co.uk

Browse 72 market data Tables and 59 Figures spread through 155 Pages and in-depth TOC on "Poultry Diagnostics Market" Early buyers will receive 10% customization on this report. The growth of the market during the forecast period is mainly driven by the increase in the avian diseases outbreak and zoonotic diseases, increasing adoption of vaccinations, diagnostic monitoring of birds for the presence of disease pathogens, and the rising consumer concerns regarding food safety. However, high cost of production, lack of animal healthcare awareness, and trade disputes such as import bans are expected to restrain the overall market growth, to a certain extent, during the forecast period. In this report, the Poultry Diagnostics Market is segmented on the basis of product, service, and region. On the basis of product, the market has been further segmented by test type and disease type. The test type segment accounted for the largest share of the market in 2016. It is also expected to grow at the highest CAGR during the forecast period. This can be attributed to the wide use of ELISA tests for preliminary screening of all avian diseases coupled with their high sensitivity, specificity, and cost-effective nature. These tests are the most preferred for fast and accurate results. The disease type is also expected to register the fastest growth in the Poultry Diagnostics Market during the forecast period. This is due to the recent surge in avian influenza outbreaks in countries like the U.S., Canada, and China. This has led to the adoption of various test kits to detect and combat its spread. By service, the market is segmented by bacteriology, virology, and parasitology. The bacteriology service segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the regular bacterial testing on poultry undertaken by regions like Europe and Asia-Pacific to detect and prevent the spread of zoonotic diseases like salmonellosis, pasteurellosis, and mycoplasmosis. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific region is expected to witness the highest growth during the forecast period. Growth in this region can be attributed to the large livestock population in this region, growing demand of poultry-derived food products, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China. Some of the prominent players in the Poultry Diagnostics Market are IDEXX Laboratories, Inc. (U.S.), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (U.S.), Zoetis, Inc. (U.S.), GD Animal Health (Netherlands), IDVet (France), AffiniTech, LTD. (U.S.), AgroBioTek Internacional (Honduras), BioNote, Inc. (South Korea), BioChek (Netherlands), Boehringer Ingelheim (Germany), MEGACOR Diagnostik GmbH (Germany), and BioinGentech Biotechnologies, Inc. (Chile). Veterinary Diagnostics Market by Product (Instruments, Consumables, Services) by Technology (Diagnostic Imaging, Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics) by Animal (Dogs, Cats, Horses, Cattle, Pigs, Poultry) - Global forecast to 2021. MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


The global clinical chemistry analyzers market to grow at a CAGR of 2.24% during the period 2017-2021. The report, Global Clinical Chemistry Analyzers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The latest trend gaining momentum in the market is focus on fully automated clinical chemistry analyzers. In the last few years, clinical chemistry analyzers have been undergoing major changes in design and function. Typically, the POC monitoring of anticoagulation is done in outpatient anticoagulation clinics, cardiac surgery units, intensive care units (ICUs), and dialysis units with the help of different technologies. There are fully automated clinical chemistry analyzers available in the market that can perform functions such as recognition of sample and reagent bottles, tube sampling, cap piercing, automatic re-run, and dilution. According to the report, one of the major drivers for this market is rising demand for automation and integration of multiple processes. Clinical laboratories rely on progressing levels of automation to solve persistent challenges that include lack of skilled personnel, pressures to maintain cost while increasing productivity, and errors associated with manual processes. Key Topics Covered: PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction PART 05: Market landscape PART 06: Market segmentation by product PART 07: Market segmentation by end-users PART 08: Geographical segmentation PART 09: Decision framework PART 10: Drivers and challenges PART 11: Market trends PART 12: Vendor landscape PART 13: Key vendor analysis PART 14: Appendix For more information about this report visit http://www.researchandmarkets.com/research/whf3th/global_clinical Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-clinical-chemistry-analyzers-market-to-grow-at-a-cagr-of-22-by-2021---key-vendors-are-abbott-laboratories-f-hoffmann-la-roche--thermo-fisher-scientific-300455094.html

Loading Clinical Chemistry collaborators
Loading Clinical Chemistry collaborators